Related Experiment Video
Updated: Aug 22, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Methylphenidate cross-sensitization with amphetamine is dose dependent but not age dependent
Anthony Yuan1, Natasha Kharas1, Nicholas King1
1Department of Neurobiology and Anatomy, University of Texas Health at the McGovern Medical School, 6431 Fannin Street, Houston TX 77030, United States.
Early methylphenidate (MPD) exposure in rats can lead to later cross-sensitization with amphetamine (AMP), but this effect is dose-dependent. Higher MPD doses in adolescence or adulthood increased AMP response, while lower doses did not.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Psychostimulants like methylphenidate (MPD) and amphetamine (AMP) are widely used in children and adolescents.
- The long-term effects of early MPD exposure on later responses to psychostimulants are not well understood.
Purpose of the Study:
- To investigate if MPD exposure in young rats leads to dependence-like behaviors.
- To determine if the age of initial MPD exposure influences later responses to MPD and AMP.
- To assess cross-sensitization between MPD and AMP after adolescent or adult MPD exposure.
Main Methods:
- Male rats were exposed to chronic MPD (0.6, 2.5, or 10.0 mg/kg) during adolescence only, adulthood only, or both periods.
- Following MPD exposure, all rats received a single AMP challenge dose in adulthood.
- Behavioral responses were monitored to assess cross-sensitization between MPD and AMP.
Main Results:
- MPD exposure at 2.5 and 10.0 mg/kg during adolescence and/or adulthood induced cross-sensitization with AMP.
- Lower MPD doses (0.6 mg/kg) did not result in cross-sensitization with AMP.
- The development of cross-sensitization between MPD and AMP was found to be dose-dependent.
Conclusions:
- Adolescent and/or adult exposure to moderate to high doses of MPD can prime the brain for enhanced responses to AMP later in life.
- MPD's potential to induce cross-sensitization with AMP is contingent on the dose administered.
- These findings highlight the importance of dose and age of exposure when considering the long-term neurobehavioral impact of psychostimulants.
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Desensitization and Tachyphylaxis
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

